| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Return on Equity | -30.276 | -41.31 | -28.298 |
| Net Profit Margin | -3,544.313 | -31,387.805 | -13,181.132 |
| Debt to Asset Ratio | 57.088 | 52.6 | 49.545 |
| Cash Ratio | 54.082 | 82.84 | 472.012 |
| Quick Ratio | 983.289 | 871.652 | 768.928 |
| Current Ratio | 983.289 | 871.652 | 768.928 |
Silence Therapeutics plc (SLNCF)
Silence Therapeutics plc (SLNCF)